Cue Biopharma (CUE) announced that Lucinda Warren, who has served as Cue Biopharma’s chief financial and business officer since February and previously as Cue Biopharma’s chief business officer from September 2024 until February, has been appointed interim president and CEO. Usman Azam has stepped down as president and CEO and as a director, effective March 26.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: